156 related articles for article (PubMed ID: 11162507)
1. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.
Yoo BC; Kim SH; Cairns N; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2001 Jan; 280(1):249-58. PubMed ID: 11162507
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of molecular chaperones in brain of patients with Down syndrome.
Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
[TBL] [Abstract][Full Text] [Related]
3. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
Yoo BC; Fountoulakis M; Cairns N; Lubec G
Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1.
Yoo BC; Fountoulakis M; Dierssen M; Lubec G
J Neural Transm Suppl; 2001; (61):321-34. PubMed ID: 11771755
[TBL] [Abstract][Full Text] [Related]
6. Developmental changes of heat-shock proteins in porcine testis by a proteomic analysis.
Huang SY; Tam MF; Hsu YT; Lin JH; Chen HH; Chuang CK; Chen MY; King YT; Lee WC
Theriogenology; 2005 Dec; 64(9):1940-55. PubMed ID: 15951011
[TBL] [Abstract][Full Text] [Related]
7. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
Sizova D; Charbaut E; Delalande F; Poirier F; High AA; Parker F; Van Dorsselaer A; Duchesne M; Diu-Hercend A
Neurobiol Aging; 2007 Mar; 28(3):357-70. PubMed ID: 16519965
[TBL] [Abstract][Full Text] [Related]
9. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains.
Wilhelmus MM; Otte-Höller I; Wesseling P; de Waal RM; Boelens WC; Verbeek MM
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):119-30. PubMed ID: 16599941
[TBL] [Abstract][Full Text] [Related]
10. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
11. Identification of oxidized plasma proteins in Alzheimer's disease.
Choi J; Malakowsky CA; Talent JM; Conrad CC; Gracy RW
Biochem Biophys Res Commun; 2002 May; 293(5):1566-70. PubMed ID: 12054695
[TBL] [Abstract][Full Text] [Related]
12. Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy.
Tessari P; Puricelli L; Iori E; Arrigoni G; Vedovato M; James P; Coracina A; Millioni R
J Proteome Res; 2007 Mar; 6(3):976-86. PubMed ID: 17330940
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
14. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
[TBL] [Abstract][Full Text] [Related]
16. Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue.
Frischer T; Myung JK; Maurer G; Eichler I; Szepfalusi Z; Lubec G
Proteomics; 2006 Jun; 6(11):3381-8. PubMed ID: 16637013
[TBL] [Abstract][Full Text] [Related]
17. Postmortem changes in the level of brain proteins.
Fountoulakis M; Hardmeier R; Höger H; Lubec G
Exp Neurol; 2001 Jan; 167(1):86-94. PubMed ID: 11161596
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics.
Short DM; Heron ID; Birse-Archbold JL; Kerr LE; Sharkey J; McCulloch J
Proteomics; 2007 Sep; 7(17):3085-96. PubMed ID: 17676660
[TBL] [Abstract][Full Text] [Related]
19. Identification of the molecular chaperone alpha B-crystallin in demineralized bone powder and osteoblast-like cells.
Behnam K; Murray SS; Whitelegge JP; Brochmann EJ
J Orthop Res; 2002 Nov; 20(6):1190-6. PubMed ID: 12472228
[TBL] [Abstract][Full Text] [Related]
20. MALDI mass spectrometric imaging of biological tissue sections.
Rohner TC; Staab D; Stoeckli M
Mech Ageing Dev; 2005 Jan; 126(1):177-85. PubMed ID: 15610777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
